HCPCS code A9542 — In111 ibritumomab, dx.
Status: Active.
Effective Jan 1, 2025.
Source: CMS HCPCS Level II.
A9542
ActiveIn111 ibritumomab, dx
Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries
Category:
Transportation & Supplies
Section:
A-codes: Transportation, Medical & Surgical Supplies
Effective:
Jan 1, 2025
Code type:
alphanumeric
OPPS Status:
N
— Items / services packaged into APC rates
MUE — Medically Unlikely Edits
Maximum units of A9542 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 1 |
| Practitioner Services | 1 |
Source: CMS Medicare NCCI Medically Unlikely Edits
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2025-Q1In111 ibritumomab, dx